Advancing regenerative medicine for real-world clinical impact

LIGO is an innovative biodelivery device designed to transform regenerative surgery. Current tissue replacement solutions often fall short, requiring extensive grafting, prolonged culture times, or high costs—all leading to suboptimal healing and limited adoption. LIGO overcomes these barriers by enabling precise, in-situ soft tissue reconstruction, creating natural layers directly at the treatment site.

The first clinical application: Skin regeneration

LIGO’s first clinical focus is on skin regeneration, tackling a critical challenge in treating deep partial-thickness and full-thickness wounds. Current approaches often require flap procedures or taking grafts from donor site, introducing surgical complexity and prolonged recovery times. LIGO has the ability to reconstruct all layers of the tissue enabling regeneration in a physiological manner with the potential to enhance healing, improve integration, and ultimately reduce or eliminate the need for grafts altogether.

By advancing soft tissue reconstruction, LIGO is designed to:

• Simplify surgical procedures and reduce complexity
• Accelerate recovery by enhancing tissue integration
• Lower healthcare costs by minimizing donor site requirements
• Expand accessibility to regenerative treatments for more patients

A first-in-class regenerative biodelivery device

LIGO marks a fundamental shift in soft tissue repair—combining surgical robotics and bioengineering to enable precision-guided, in-situ tissue reconstruction. Unlike traditional grafting techniques, which rely on surgeon skill and available donor tissue, LIGO standardizes and optimizes soft tissue repair for better outcomes.

• Precision & reproducibility: Streamlined, standardized soft tissue reconstruction—removing variability from manual techniques.
• Seamless clinical integration: Designed for direct use in surgical settings, no extended culture times or specialized facilities required.
• Configurable output for personalized treatment: Adjustable biodelivery system for precise control over dose and complexity, enabling tailored treatment.
• Setting a new standard in regeneration medicine: Moves soft tissue reconstruction beyond outdated grafting techniques into the next era of robotic precision and regenerative medicine.
• Designed for better clinical & patient outcomes: LIGO has the potential to shorten recovery times, improve surgical outcomes, and enhance long-term tissue function.